BEONE MEDICINES LTD.: proceeds from issuing common stock
Proceeds from issuing common stock for BEONE MEDICINES LTD. Inspect selected reporting periods, original units and SEC filing links; download the financial history.
All BEONE MEDICINES LTD. financial histories
What this measure means
Cash received from issuing common stock during the period. It is gross of costs only where the filer reports it so, and it does not include noncash issuances.
Exact concept: us-gaap:ProceedsFromIssuanceOfCommonStock. Each value covers an annual-duration reporting interval, shown with both start and end dates. Different units remain separate; no currency conversion or interpolation is applied.
Coverage of this history
Selected reporting periods run from 2016-01-01 to 2023-12-31. The SEC response was captured on 2026-09-21.
This selected history ends more than two years before capture. Do not treat its final value as a current balance or current annual result. More recent filings may use another accounting tag; inspect the filings before drawing conclusions about the company.
Selected filing history
| Period start | Period end | Value | Unit | Filed | Source filing |
|---|---|---|---|---|---|
| 2023-01-01 | 2023-12-31 | 0 | USD | 2024-02-26 | 10-K · 0001651308-24-000014 |
| 2022-01-01 | 2022-12-31 | 0 | USD | 2024-02-26 | 10-K · 0001651308-24-000014 |
| 2021-01-01 | 2021-12-31 | 50,000,000 | USD | 2024-02-26 | 10-K · 0001651308-24-000014 |
| 2020-01-01 | 2020-12-31 | 4,232,017,000 | USD | 2023-02-27 | 10-K · 0001651308-23-000036 |
| 2019-01-01 | 2019-12-31 | 0 | USD | 2022-02-28 | 10-K · 0001651308-22-000032 |
| 2018-01-01 | 2018-12-31 | 0 | USD | 2021-02-25 | 10-K · 0001651308-21-000039 |
| 2017-01-01 | 2017-12-31 | 149,928,000 | USD | 2020-03-02 | 10-K · 0001651308-20-000020 |
| 2016-01-01 | 2016-12-31 | 0 | USD | 2019-02-28 | 10-K · 0001651308-19-000018 |
Related financial histories
- BEONE MEDICINES LTD.: total assets
- BEONE MEDICINES LTD.: total liabilities
- BEONE MEDICINES LTD.: stockholders equity
- BEONE MEDICINES LTD.: cash and cash equivalents
- BEONE MEDICINES LTD.: net income or loss
- BEONE MEDICINES LTD.: operating cash flow
- BEONE MEDICINES LTD.: capital expenditure payments
- BEONE MEDICINES LTD.: revenue
- BEONE MEDICINES LTD.: contract revenue excluding tax
- BEONE MEDICINES LTD.: financing cash flow
- BEONE MEDICINES LTD.: investing cash flow
- BEONE MEDICINES LTD.: retained earnings or deficit
- BEONE MEDICINES LTD.: basic weighted-average shares
- BEONE MEDICINES LTD.: diluted weighted-average shares
- BEONE MEDICINES LTD.: basic earnings per share
- BEONE MEDICINES LTD.: diluted earnings per share
- BEONE MEDICINES LTD.: income tax expense or benefit
- BEONE MEDICINES LTD.: net property, plant and equipment
- BEONE MEDICINES LTD.: share-based compensation expense
- BEONE MEDICINES LTD.: operating income or loss
- BEONE MEDICINES LTD.: current assets
- BEONE MEDICINES LTD.: current liabilities
- BEONE MEDICINES LTD.: current accounts payable
- BEONE MEDICINES LTD.: net finite-lived intangible assets
- BEONE MEDICINES LTD.: net current accounts receivable
- BEONE MEDICINES LTD.: net inventory
- BEONE MEDICINES LTD.: gross profit
- BEONE MEDICINES LTD.: selling, general and administrative expense
- BEONE MEDICINES LTD.: research and development expense
- BEONE MEDICINES LTD.: common shares outstanding
- BEONE MEDICINES LTD.: cash including restricted cash
- BEONE MEDICINES LTD.: additional paid-in capital
- BEONE MEDICINES LTD.: accumulated other comprehensive income or loss
- BEONE MEDICINES LTD.: total equity including noncontrolling interests
- BEONE MEDICINES LTD.: operating lease right-of-use asset
- BEONE MEDICINES LTD.: operating lease liability
- BEONE MEDICINES LTD.: gross property, plant and equipment
- BEONE MEDICINES LTD.: accumulated depreciation on property, plant and equipment
- BEONE MEDICINES LTD.: other noncurrent assets
- BEONE MEDICINES LTD.: other noncurrent liabilities
- BEONE MEDICINES LTD.: accrued current liabilities
- BEONE MEDICINES LTD.: prepaid expenses and other current assets
- BEONE MEDICINES LTD.: current contract liabilities
- BEONE MEDICINES LTD.: net deferred tax assets
- BEONE MEDICINES LTD.: net deferred tax liabilities
- BEONE MEDICINES LTD.: pre-tax income or loss from continuing operations
- BEONE MEDICINES LTD.: profit or loss including noncontrolling interests
- BEONE MEDICINES LTD.: comprehensive income or loss
- BEONE MEDICINES LTD.: net income available to common stockholders
- BEONE MEDICINES LTD.: general and administrative expense
- BEONE MEDICINES LTD.: depreciation expense
- BEONE MEDICINES LTD.: depreciation, depletion and amortization
- BEONE MEDICINES LTD.: amortization of intangible assets
- BEONE MEDICINES LTD.: nonoperating interest expense
- BEONE MEDICINES LTD.: other nonoperating income or expense
- BEONE MEDICINES LTD.: current income tax expense or benefit
- BEONE MEDICINES LTD.: deferred income tax expense or benefit
- BEONE MEDICINES LTD.: interest paid, net
- BEONE MEDICINES LTD.: income taxes paid, net
- BEONE MEDICINES LTD.: operating lease payments
- BEONE MEDICINES LTD.: change in accounts receivable
- BEONE MEDICINES LTD.: change in inventories
- BEONE MEDICINES LTD.: change in accounts payable
Inspect the source
- Entity
- BEONE MEDICINES LTD. / CIK 0001651308
- Captured
- 2026-09-21T17:23:34.962Z
- SEC response SHA-256
e52f414c5378460828e658b33687af7af29160a9ee9f5cebae472b599520e827
Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON
Latest-filed annual-report facts per unit and reporting period at capture time. Duration facts cover 300 to 400 days. This selection can include restatements and is not a point-in-time backtest dataset. Missing concepts are omitted, never zero-filled. Values retain original units and are not currency converted. Extended concepts require compatible unit shapes and at least three reporting ends with changing values within one unit. Constant or incompatible added histories are omitted.
Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.
Use this in research
A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.
These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.
Research methodology · Execution and cost assumptions · Check backtest overfitting
Build with the open-source tools
Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.
- Get an API key and run your first validation
- Connect the MCP server to your coding assistant
- Inspect the ALPHAC engine on GitHub
- Read the MCP server source and integration examples
Read the published dataset with Python
import json
from urllib.request import urlopen
with urlopen("https://canlicapital.com/company-data/0001651308.json") as response:
record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
print(concept["tag"], next(iter(concept["observations"])))